Written answers
Thursday, 1 June 2017
Department of Health
Medicinal Products Availability
John Brassil (Kerry, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
171. To ask the Minister for Health the status of the updated submission by a company (details supplied) to bring Translarna for the treatment of Duchenne muscular dystrophy here; the reason for the delay in advancing the decision by the HSE; the date for a decision to be reached; and if he will make a statement on the matter. [26359/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments